Lsv Asset Management Meridian Bioscience Inc Transaction History

Lsv Asset Management

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$23.75 - $31.69 $3.08 Million - $4.11 Million	-129,541 Reduced 64.98%	69,800 $2.12 Million
Q1 2022 May 12, 2022	SELL	$19.97 - $26.94 $4.25 Million - $5.74 Million	-212,937 Reduced 51.65%	199,341 $5.18 Million
Q4 2021 Jan 28, 2022	BUY	$17.46 - $21.61 $451,341 - $558,618	25,850 Added 6.69%	412,278 $8.41 Million
Q3 2021 Nov 04, 2021	SELL	$17.35 - $22.5 $232,490 - $301,500	-13,400 Reduced 3.35%	386,428 $7.43 Million
Q2 2021 Aug 04, 2021	SELL	$18.01 - $28.32 $97,254 - $152,928	-5,400 Reduced 1.33%	399,828 $8.87 Million
Q1 2021 Apr 30, 2021	BUY	$19.76 - $29.89 $2.21 Million - $3.35 Million	111,928 Added 38.16%	405,228 $10.6 Million
Q4 2020 Feb 08, 2021	BUY	$15.73 - $21.66 $4.35 Million - $5.99 Million	276,500 Added 1645.83%	293,300 $5.48 Million
Q3 2020 Oct 23, 2020	BUY	$13.54 - $26.41 $227,472 - $443,688	16,800 New	16,800 $285,000
Q1 2020 May 07, 2020	SELL	$5.57 - $11.5 $611,586 - $1.26 Million	-109,800 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$9.17 - $12.01 $105,455 - $138,115	11,500 Added 11.7%	109,800 $1.04 Million
Q1 2019 May 07, 2019	SELL	$15.51 - $17.61 $440,484 - $500,124	-28,400 Reduced 22.42%	98,300 $1.73 Million
Q4 2018 Feb 05, 2019	SELL	$14.52 - $19.72 $341,220 - $463,420	-23,500 Reduced 15.65%	126,700 $2.2 Million
Q3 2018 Nov 06, 2018	SELL	$14.85 - $16.35 $206,415 - $227,265	-13,900 Reduced 8.47%	150,200 $2.24 Million
Q1 2018 May 04, 2018	BUY	$13.8 - $16.2 $2.26 Million - $2.66 Million	164,100 New	164,100 $2.33 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

Stay updated on Lsv Asset Management with notifications on news.